Hampton to Become GlaxoSmithKline Chairman on May 7
February 26 2015 - 11:09AM
Dow Jones News
By Tapan Panchal
LONDON--GlaxoSmithKline PLC (GSK.LN) confirmed on Thursday that
Philip Hampton, the current chairman of Royal Bank of Scotland
Group PLC (RBS.LN), will become the chairman of the pharmaceutical
company on May 7.
Mr. Hampton was named as the new chairman in September. He will
replace Christopher Gent, who will step down at the annual general
meeting on May 7. Mr. Hampton will first become deputy chairman on
April 1 and then take over as chairman at the end of the annual
meeting.
Mr. Hampton will remain chairman of Royal Bank of Scotland until
Aug. 31, Glaxo said.
Write to Tapan Panchal at tapan.panchal@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Royal Bank of Scotland (NYSE:RBS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Royal Bank of Scotland (NYSE:RBS)
Historical Stock Chart
From Sep 2023 to Sep 2024